New Study : Hepatitis Drugs Could Serve as Coronavirus Treatment
Two hepatitis C (HCV) antiviral drugs were found to raise survival rates for people with moderate or severe COVID-19 according to a series of Iranian studies reported at the online International AIDS Conference last week.
Study co-author Andrew Hill, MD, of Liverpool University said the antiviral drugs sofosbuvir and daclatasvir could offer an affordable and widely accessible treatment option, according to early study findings.
You May Also Like
As the global COVID-19 case numbers steadily climb, researchers are testing a plethora of medications used to treat existing conditions as potential treatments for the new coronavirus, now recently coined as SARS-CoV-2.
According to a press release, sofosbuvir and daclatasvir have shown to successfully fight against COVID-19 infection strains. For example, daclatasvir appears to penetrate well into the lungs, which is a major indicator of COVID-19 prevention since it attacks the cardiovascular system.
